Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
FEMALE
NCT04710797

Lymphadenectomy in Early Ovarian Cancer

Led by Sun Yat-sen University · Updated on 2021-01-15

656

Participants Needed

1

Research Sites

413 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To assess the impact of comprehensive staging surgery with no lymphadenectomy on survival and quality of life in patients with early-stage ovarian cancer.

CONDITIONS

Official Title

Lymphadenectomy in Early Ovarian Cancer

Who Can Participate

Age: 18Years - 70Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18 to 70 years
  • Primary diagnosis of epithelial ovarian cancer FIGO stage IA to IIA
  • No prior treatment or incomplete initial surgery
  • Indications for adjuvant chemotherapy including high-grade serous carcinoma, grade 3 endometrioid carcinoma, clear cell carcinoma, grade 2 endometrioid carcinoma with capsule rupture or pelvic tissue extension, low-grade serous carcinoma, grade 1 endometrioid carcinoma, and mucinous carcinoma with pelvic tissue extension
  • Signed and written informed consent given
  • Good performance status (ECOG 0 or 1)
Not Eligible

You will not qualify if you...

  • Non-epithelial ovarian malignancies and borderline tumors
  • Suspicious lymph nodes seen on preoperative imaging
  • Clinically suspicious or bulky lymph nodes during surgery
  • Secondary invasive cancers within the last 5 years except certain early-stage cancers
  • Prior chemotherapy for ovarian cancer or pelvic/abdominal radiotherapy
  • Diseases of the lymph system including unexplained lymphedema
  • Prior retroperitoneal lymph node dissection
  • Other medical conditions that contraindicate surgery
  • Pregnancy
  • Any factors preventing informed consent, protocol compliance, or regular follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China, 510060

Actively Recruiting

Loading map...

Research Team

J

Jihong Liu, Ph.D.

CONTACT

T

Ting Deng, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Lymphadenectomy in Early Ovarian Cancer | DecenTrialz